Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone-Reference-Cited by-同舟云学术

Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone

Published:1999-02 Issue:2 Volume:16 Page:147-153
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Buysschaert M.,Bobbioni E.,Starkie M.,Frith L.,Group for the Troglitazone Study

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-5491.1999.00029.x/fullpdf

Reference15 articles.

1. A Desktop Guide for the Management of Non-insulin-dependent Diabetes Mellitus (NIDDM): An Update

2. Biguanides and Sulfonylureas as Combination Therapy in NIDDM

3. Double-masked, placebo-controlled, dose-ranging study of troglitazone 10 to 200 mg once daily in non—insulin-dependent diabetes mellitus

4. Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network meta-analysis of glucose-lowering drug treatment regimens with the potential risk of hypoglycemia in patients with type 2 diabetes mellitus in terms of glycemic control and severe hypoglycemia;Journal of Investigative Medicine;2023-01-25

2. Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus;BMC Medicine;2020-11-16

3. Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes;Nutrients;2019-08-28

4. Thiazolidinediones;Meyler's Side Effects of Drugs;2016

5. Sulfonylureas;Meyler's Side Effects of Drugs;2016